Johannsen, Trine Holm http://orcid.org/0000-0002-3303-5352
Ljubicic, Marie Lindhardt http://orcid.org/0000-0002-7418-6878
Young, Jacques http://orcid.org/0000-0001-9286-5631
Trabado, Séverine http://orcid.org/0000-0002-1925-1999
Petersen, Jørgen Holm http://orcid.org/0000-0003-3979-7443
Linneberg, Allan http://orcid.org/0000-0002-0994-0184
Albrethsen, Jakob http://orcid.org/0000-0002-2842-1128
Juul, Anders http://orcid.org/0000-0002-0534-4350
Funding for this research was provided by:
The Absalon Foundation
Article History
Received: 30 October 2020
Accepted: 5 January 2021
First Online: 22 January 2021
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Denmark: The study was approved by the ethics committees of the Capital Region of Denmark (H-KA20060011). All patient samples were taken as part of the clinical follow-up. Access to Danish patient data was approved by the Danish Patient Safety Authority (no. 3–3013–1376/1/) and the Danish Data Protection Agency (no. 2015–235, I-Suite no. 04204). In Denmark, the permission for INSL3 measurements was approved as part of a quality assurance project at Rigshospitalet, University Hospital of Copenhagen (approval no. 20012618). France: The study was approved by Assistance Publique-Hôpitaux de Paris and the institutional review boards at Bicêtre teaching hospital (Comité de Protection des Personnes Ile de France, Hôpital Bicêtre, Programme Hospitalier de Recherche Clinique [PHRC-2009, Hypoproteo].
: France: All participants gave written informed consent according to the French Bioethics Law and the Declaration of Helsinki.